Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Notice to Readers: Changes in National Notifiable Diseases List and
Data Presentation
This issue of MMWR incorporates modifications to Tables I and II Cases of Notifiable Diseases, United States. This
year, the modifications add diseases designated nationally notifiable by the Council of State and Territorial
Epidemiologists
(CSTE) in conjunction with CDC. As of January 1, 2003, three disease have been added to the list of nationally
notifiable diseases: chronic hepatitis B infection, hepatitis C virus infection (past or present), and varicella (Table 1). Incidence data
for chronic hepatitis B infection and hepatitis C virus infection (past or present) will not be presented in the weekly
MMWR tables pending evaluation of the data by the Division of Viral Hepatitis, National Center for Infectious Diseases. Except where indicated, National Notifiable Diseases Surveillance System (NNDSS) data presented in the notifiable disease tables are transmitted to CDC through the National Electronic Telecommunications System for Surveillance (NETSS).
Additional information about nationally notifiable diseases, NNDSS, NETSS, and CSTE is available at
http://www.cdc.gov/epo/dphsi/phs.htm and
http://www.cste.org.
Modifications to Table I
Provisional incidence data for diseases with annual incidence of <300 cases in the United States or diseases that
are designated as notifiable in <25 states are presented in Table I. Measles (total), mumps, rubella, and congenital rubella syndrome data have been added to Table 1. A Table I footnote will specify the total number of indigenous and
imported measles cases comprising total reported measles incidence.
Modifications to Table II
Provisional incidence data for diseases with annual incidence of
>300 cases in the United States and diseases that
are designated as notifiable in >25 states are presented in Table II. For clarity of notifiable disease data presentation, if any distinct manifestation of a disease meets the Table II criteria, all distinct disease conditions related to Table II-eligible diseases will be included in Table II. As of January 6, 2003, three diseases have been added to Table II: coccidioidomycosis, West
Nile encephalitis/meningitis, and varicella. Acute hepatitis C virus infection data are presented as a separate category, and
acute hepatitis non-A, non-B incidence data are no longer presented in Table II.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
